Biotech Series A Investors & VC Firms
1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.
Regeneration.VC
Redondo BeachPre-Seed–Series A$1M – $3M
10 people
Amino Collective
BerlinPre-Seed–Series A$216K – $1.6M
8 people
DeepTech & Climate Fonds
MunichSeries A–Growth$5.5M – $55M
15 people
Sciety
StockholmSeed–Growth
21 people
Catalytic Impact Foundation
HinghamPre-Seed–Series A
8 people
Green Pine Capital Partners
ShenzhenPre-Seed–Series B
2 people
Auriga Partners
ParisSeed–Growth$540K – $5.4M
16 people
Delos Capital
CambridgeSeed–Growth
13 people
Eaton Square
LondonSeries A–Growth
25 people
Crossbeam Venture Partners
New YorkPre-Seed–Late Stage$1M – $1.5M
8 people
Neva Sgr.
TurinSeries A–Growth
8 people
Avalon Ventures Management, Llc
La JollaPre-Seed–Series A$500K – $10M
9 people
The Yield Lab Europe
DublinSeed–Series A$108K – $2.2M
9 people
Expon Capital
LuxembourgSeed–Growth$550K – $1.6M
5 people
Creathor Ventures
Bad HomburgSeed–Late Stage$540K – $10.8M
2 people
Verdex Capital
CalgarySeed–Series A
10 people
Invus
New YorkSeed–Late Stage
8 people
MedTech Actuator
Seed–Series B
Micron Ventures
BoisePre-Seed–Series A
12 people
HBM Partners
ZugSeed–Late Stage$5M – $50M
6 people
IU Ventures
BloomingtonSeed–Series A
1 person
V-Bio Ventures
GhentSeed–Series B$270K – $2.2M
13 people
Scottish Enterprise
GlasgowSeed–Growth
6 people
Simon Capital
DüsseldorfSeed–Growth$540K – $10.8M
9 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Series A Investors & VC Firms in United States (3838)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Biotech Investors & VC Firms (2475)Series A Investors & VC Firms in Europe (2383)Fintech Series A Investors & VC Firms (2349)Healthtech Series A Investors & VC Firms (2309)Enterprise Software Series A Investors & VC Firms (2264)
Data sourced from public filings and firms' own websites — see our methodology.





























































































